[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study]. Magdolna S Ideggyogy Sz. 2014 May 30; 67(5-6):211-2. PMID: 25087382. Abstract CommentRecommendBookmarkWatch